Replies to post #1094 on Synvista Therapeutics Inc (SYNI)

[es1]

I agree that potential is here but I dont call Gonz "people".

I would say with 2M shares and FDA it is more apt to go to over $100. But dont quote me as "people that said"LOL
Just considering Dendron went to 60 after FDA and It has basically the same share structure. Their drug only added 2-4 month to someones life and it was extremely expencive and they broke $60.

I would like to see some actual info on the company. It seems after delisting the have never spoken a word in public.

I find it odd (and refreshing) to not see endless pumps but It would be nice for the company to give us a bone.